Highlights

  • Nufarm expected underlying EBITDA to rise approximately 25% for FY26 against the previous financial year.
  • Management projected Leverage of approximately 2.0 times, alongside positive free Cash Flow and improved working capital.
  • Seed Technologies growth was expected to come from Hybrid Seeds and Omega-3 businesses.
  • A strategy refresh targeted AUD 50M of annualised cost savings by the end of FY27.

Nufarm Limited (ASX:NUF) is advancing a company-specific operating and development programme against the backdrop of its latest reported financial and project milestones. Its shares closed at AUD 3.40 on 3 November 2026, a daily change of 1.49%, with a Market Capitalisation of approximately AUD 1.31B. The company’s disclosed progress spans the activities outlined below, with completed results distinguished from management targets and projects still under development.

Earnings Guidance Establishes the Financial Agenda

In its 23 September 2026 trading update, Nufarm outlined expectations for approximately 25% growth in underlying EBITDA for FY26. This was guidance rather than a completed audited result, and the company linked its outlook to improving Earnings and operating discipline. The same update anticipated positive free cash flow and a material reduction in leverage to around 2.0 times. Those expectations provided measurable objectives for the financial year, but they remain distinct from reported final accounts.

Seed Technologies Adds Another Growth Channel

Nufarm expected its Seed Technologies division to generate strong underlying EBITDA growth compared with the prior year. Management identified Hybrid Seeds and Omega-3 as contributors. The update therefore presented the seed Business as an important component of group performance rather than treating crop protection as the sole operating focus. The company did not provide a final divisional profit figure in the September guidance, so the anticipated improvement should not be confused with a completed result.

Cost Reduction Programme Enters Execution

The company also described progress on its strategy refresh. Its stated objectives included simplifying operations, reducing costs and improving returns. Nufarm targeted AUD 50M in run-rate cost savings by the end of FY27, a forward-looking goal with a later deadline than the FY26 earnings guidance. Investors assessing this programme can distinguish the near-term expectation of improved profitability from the longer timetable for the full cost savings. The company said initiatives were already underway.

Financial Discipline and Trading Context

The September update placed Working Capital and cash generation alongside earnings as priorities. Stronger underlying EBITDA alone would not establish the delivery of the leverage target; the company specifically referred to cash generation and disciplined working capital management. On 3 November 2026, Nufarm shares closed at AUD 3.40, up 1.49%, after trading between AUD 3.35 and AUD 3.46. Its market capitalisation was approximately AUD 1.31B, with a reported one-year change of 61.14%.

What Comes Next

The next financial reporting milestone is the publication of results against the company’s FY26 expectations. Progress on Hybrid Seeds, Omega-3, working capital and the simplification programme will provide the context for assessing execution. The AUD 50M run-rate savings target remains a goal for the end of FY27, not a saving already realised. The company’s 28 September investor presentation followed its trading update and provided another scheduled communication on strategy. The difference between near-term FY26 expectations and the FY27 savings timetable is central to interpreting the sequence of commitments.